These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8219934)

  • 1. Urinary collagen crosslink excretion: a better index of bone resorption than hydroxyproline in Paget's disease of bone?
    Hamdy NA; Papapoulos SE; Colwell A; Eastell R; Russell RG
    Bone Miner; 1993 Jul; 22(1):1-8. PubMed ID: 8219934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of the outcome of treatment of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption.
    Papapoulos SE; Frölich M
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3993-7. PubMed ID: 8923849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of different markers of bone resorption in postmenopausal osteoporotic women treated with pamidronate.
    Kollerup G; Sørensen HA; Hyldstrup L; Storm T
    Scand J Clin Lab Invest; 1997 Oct; 57(6):479-86. PubMed ID: 9350066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.
    Garnero P; Gineyts E; Riou JP; Delmas PD
    J Clin Endocrinol Metab; 1994 Sep; 79(3):780-5. PubMed ID: 8077361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of salmon calcitonin on deoxypyridinoline (Dpyr) urinary excretion in healthy volunteers.
    Abbiati G; Arrigoni M; Frignani S; Longoni A; Bartucci F; Castiglioni C
    Calcif Tissue Int; 1994 Nov; 55(5):346-8. PubMed ID: 7866914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyridinium crosslinks of collagen as a marker of bone resorption rates in children and adolescents: normal values and clinical application.
    Marowska J; Kobylińska M; Lukaszkiewicz J; Tałajko A; Rymkiewicz-Kluczyńska B; Lorenc RS
    Bone; 1996 Dec; 19(6):669-77. PubMed ID: 8968036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases.
    Robins SP; Black D; Paterson CR; Reid DM; Duncan A; Seibel MJ
    Eur J Clin Invest; 1991 Jun; 21(3):310-5. PubMed ID: 1909635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiresorptive effect of a single infusion of microgram quantities of zoledronate in Paget's disease of bone.
    Arden-Cordone M; Siris ES; Lyles KW; Knieriem A; Newton RA; Schaffer V; Zelenakas K
    Calcif Tissue Int; 1997 May; 60(5):415-8. PubMed ID: 9115157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of bisphosphonates on new and traditional markers of bone resorption.
    Pedrazzoni M; Alfano FS; Gatti C; Fantuzzi M; Girasole G; Campanini C; Basini G; Passeri M
    Calcif Tissue Int; 1995 Jul; 57(1):25-9. PubMed ID: 7671161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
    Alvarez L; Guañabens N; Peris P; Monegal A; Bedini JL; Deulofeu R; Martinez de Osaba MJ; Muñoz-Gomez J; Rivera-Fillat F; Ballesta AM
    J Bone Miner Res; 1995 Mar; 10(3):458-65. PubMed ID: 7785468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pamidronate and biochemical markers of bone turnover.
    Martínez ME; Del Campo MT; Plaza MA; Torrijos A; Gijón J
    Scand J Clin Lab Invest; 1997 Nov; 57(7):581-6. PubMed ID: 9397488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity.
    Alvarez L; Peris P; Pons F; Guañabens N; Herranz R; Monegal A; Bedini JL; Deulofeu R; Martínez de Osaba MJ; Muñoz-Gómez J; Ballesta AM
    Arthritis Rheum; 1997 Mar; 40(3):461-8. PubMed ID: 9082934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion.
    Garnero P; Gineyts E; Arbault P; Christiansen C; Delmas PD
    J Bone Miner Res; 1995 Apr; 10(4):641-9. PubMed ID: 7610936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single infusion of neridronate (6-amino-1-hydroxyhexylidene-1,1-bisphosphonate) in patients with active rheumatoid arthritis: effects on disease activity and bone resorption markers.
    Mazzantini M; Di Munno O; Metelli MR; Bulleri M; Giordani R
    Aging Clin Exp Res; 2002 Jun; 14(3):197-201. PubMed ID: 12387527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable efficacy of bone remodeling biochemical markers in the management of patients with Paget's disease of bone treated with tiludronate.
    de la Piedra C; Rapado A; Díaz Diego EM; Díaz Martín MA; Aguirre C; López Gavilanes E; Díaz Curiel M
    Calcif Tissue Int; 1996 Aug; 59(2):95-9. PubMed ID: 8687976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
    Garnero P; Gineyts E; Schaffer AV; Seaman J; Delmas PD
    Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease.
    Uebelhart D; Gineyts E; Chapuy MC; Delmas PD
    Bone Miner; 1990 Jan; 8(1):87-96. PubMed ID: 2106358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Deoxypyridinoline and other biochemical markers of bone resorption in distinct pathologies].
    Rivero Marcotegui A; Palacios Sarrasqueta M; Grijalba Uche A; Martínez Rodríguez JL; Sorbet Zubiría MJ; García Merlo S
    Rev Clin Esp; 1997 Jun; 197(6):389-92. PubMed ID: 9304127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis.
    Lems WF; Gerrits MI; Jacobs JW; van Vugt RM; van Rijn HJ; Bijlsma JW
    Ann Rheum Dis; 1996 May; 55(5):288-93. PubMed ID: 8660101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoassay of pyridinoline crosslink excretion in normal adults and in Paget's disease.
    Delmas PD; Gineyts E; Bertholin A; Garnero P; Marchand F
    J Bone Miner Res; 1993 May; 8(5):643-8. PubMed ID: 8511992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.